Lesional RhoA+ cell numbers are suppressed by anti-inflammatory, cyclooxygenase-inhibiting treatment following subacute spinal cord injury

GLIA

Volumn 47, Issue 4, 2004, Pages 377-386

  Schwab, Jan M ^a,b,c   Conrad, Sabine ^a   Elbert, Tina ^a   Trautmann, Katrin ^a   Meyermann, Richard ^a   Schluesener, Hermann J ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b Groupe Enzymologie Moléculaire et Fonctionnelle   (France)

^c UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Inflammation; Regeneration; Rho GTPases; Spinal cord injury

Indexed keywords

ANTIINFLAMMATORY AGENT; CYCLOOXYGENASE 1 INHIBITOR; CYCLOOXYGENASE 2 INHIBITOR; FREE RADICAL; GUANOSINE TRIPHOSPHATASE; INDOMETACIN; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; PROSTAGLANDIN SYNTHASE INHIBITOR; RHO KINASE; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTROCYTE; BIOACCUMULATION; CELL COUNT; CELL DENSITY; CELL MIGRATION; CELL SPECIFICITY; CONTROLLED STUDY; DRUG DOSE REGIMEN; DRUG EFFECT; DRUG EFFICACY; EDEMA; ENDOTHELIUM INJURY; ENZYME ACTIVITY; ENZYME INACTIVATION; ENZYME INHIBITION; GRANULOCYTE; HISTOPATHOLOGY; MACROPHAGE; MALE; MICROGLIA; NERVE FIBER REGENERATION; NEUROPROTECTION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SPINAL CORD FUNCTION; SPINAL CORD INJURY; STOMACH ULCER;

ACUTE DISEASE; ANIMALS; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; INDOMETHACIN; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; ISOENZYMES; MALE; MEMBRANE PROTEINS; NERVE REGENERATION; NEUROGLIA; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PROTEIN-SERINE-THREONINE KINASES; RATS; RATS, INBRED LEW; RHOA GTP-BINDING PROTEIN; SPINAL CORD INJURIES;

EID: 4644335622     PISSN: 08941491     EISSN: None     Source Type: Journal    
DOI: 10.1002/glia.20031     Document Type: Article

References (58)

1. Albas J, Ulfman L, Hordijk P, Koenderman L. 2001. Activation of RhoA and ROCK are essential for detachment of migrating leukocytes. Mol Biol Cell 12:2137-2145.
2. Angkachatchai V, Finkel TH. 1999. ADP-ribosylation of rho by C3 ribosyltransferase inhibits IL-2 production and sustained calcium influx in activated T cells. J Immunol 163:3819-3825.
3. Aznar Benitah S, Valeron PF, Lacal JC. 2003. ROCK and nuclear factor-kappaB-dependent activation of cyclooxygenase-2 by Rho GTPases: effects on tumor growth and therapeutic consequences. Mol Biol Cell 14:3041-3054.
4. Barandier C, Ming XF, Rusconi S, Yang Z. 2003. PKC is required for activation of ROCK by RhoA in human endothelial cells. Biochem Biophys Res Commun 304:714-719.
5. Bezzi P, Domercq M, Brambilla L, Galli R, Schols D, De Clercq E, Vescovi A, Bagetta G, Kollias G, Meldolesi J, Volterra A. 2001. CXCR4-activated astrocyte glutamate release via TNFalpha: amplification by microglia triggers neurotoxicity. Nat Neurosci 4:702-710.
6. Brabeck C, Mittelbronn M, Bekure K, Meyermann R, Schluesener HJ, Schwab JM. 2003. Effect of focal cerebral infarctions on lesional RhoA and RhoB expression. Arch Neurol 60:1245-1249.
7. Bradbury EJ, Moon LD, Popat RJ, King VR, Bennett GS, Patel PN, Fawcett JW, McMahon SB. 2002. Chondroitinase ABC promotes functional recovery after spinal cord injury. Nature 416:636-640.
8. Brandt D, Gimona M, Hillmann M, Haller H, Mischak H. 2002. Protein kinase C induces actin reorganization via a Src- and Rho-dependent pathway. J Biol Chem 277:20903-20910.
9. Bregman BS, Kunkel-Bagden E, Schnell L, Dai HN, Gao D, Schwab ME. 1995. Recovery from spinal cord injury mediated by antibodies to neurite growth inhibitors. Nature 378:498-501.
10. Chandrasekharan NV, Dai H, Roos KL, Evanson NK, Tomsik J, Elton TS, Simmons DL. 2002. COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression. Proc Natl Acad Sci USA 99:13926-13931.
11. Chardin P, Boquet P, Madaule P, Popoff MR, Rubin EJ, Gill DM. 1989. The mammalian G protein rhoC is ADP-ribosylated by Clostridium botulinum exoenzyme C3 and affects actin microfilaments in Vero cells. EMBO J 8:1087-1092.
12. Dergham P, Ellezam B, Essagian C, Avedissian H, Lubell WD, McKerracher L. 2002. Rho signaling pathway targeted to promote spinal cord repair. J Neurosci 22:6570-6577.
13. Dubreuil CI, Winton, MJ, McKerracher L. 2003. Rho activation patterns after spinal cord injury and the role of activated Rho in apoptosis in the central nervous system. J Cell Biol 162:233-243.
14. Eto M, Kozai T, Cosentino F, Joch H, Luscher TF. 2002. Statin prevents tissue factor expression in human endothelial cells: role of Rho/Rho-kinase and Akt pathways. Circulation 105:1756-1759.
15. Evers EE, Zondag GC, Malliri A, Price LS, ten Klooster JP, van der Kammen RA, Collard JG. 2000. Rho family proteins in cell adhesion and cell migration. Eur J Cancer 36:1269-1274.
16. Fournier AE, Strittmatter SM. 2001. Repulsive factors and axon regeneration in the CNS. Curr Opin Neurobiol 11:89-94.
17. Fournier AE, Takizawa BT, Strittmatter SM. 2003. Rho kinase inhibition enhances axonal regeneration in the injured CNS. J Neurosci 23:1416-1423.
18. Greenwood J, Walters CE, Pryce G, Kanuga N, Beraud E, Baker D, Adamson P. 2003. Lovastatin inhibits brain endothelial cell Rho-mediated lymphocyte migration and attenuates experimental autoimmune encephalomyelitis. FASEB J 17:905-907.
19. Guth L, Zhang Z, Roberts E. 1994. Key role for pregnenolone in combination therapy that promotes recovery after spinal cord injury. Proc Natl Acad Sci USA 91:12308-12312.
20. Hains BC, Yucra JA, Hulsebosch CE. 2001. Reduction of pathological and behavioral deficits following spinal cord contusion injury with the selective cyclooxygenase-2 inhibitor NS-398. J Neurotrauma 18:409-23.
21. Hall A. 1998. Rho GTPases and the actin cytoskeleton. Science 279: 509-514.
22. Hippenstiel S, Kratz T, Krull M, Seybold J, von Eichel-Streiber C, Suttorp N. 1998. Rho protein inhibition blocks protein kinase C translocation and activation. Biochem Biophys Res Commun 245: 830-834.
23. Huang DW, McKerracher L, Braun PE, David S. 1999. A therapeutic vaccine approach to stimulate axon regeneration in the adult mammalian spinal cord. Neuron 24:639-647.
24. Hurley SD, Olschowka JA, O'Banion MK. 2002. Cyclooxygenase inhibition as a strategy to ameliorate brain injury. J Neurotrauma 2002 19:1-15.
25. Jin Z, Strittmatter SM. 1997. Rac1 mediates collapsin-1-induced growth cone collapse. J Neurosci 17:6256-6263.
26. +, protein kinase C, tyrosine kinase and Rho-A. Neuropharmacology. 42:1-8.
27. Kawaguchi A, Ohmori M, Harada K, Tsuruoka S, Sugimoto K, Fujimura A. 2000. The effect of a Rho kinase inhibitor Y-27632 on superoxide production, aggregation and adhesion in human polymorphonuclear leukocytes. Eur J Pharmacol 403:203-208.
28. Knaus UG. 2000. Rho GTPase signaling in inflammation and transformation. Immunol Res 21:103-109.
29. Lehmann M, Fournier A, Selles-Navarro I, Dergham P, Sebok A. 1999. Inactivation of Rho signaling pathway promotes CNS axon regeneration. J Neurosci 19:7537-7547.
30. Luo L. 2000. Rho GTPases in neuronal morphogenesis. Nat Rev Neurosci 1:173-180.
31. Martin G, Duez H, Blanquart C, Berezowski V, Poulain P, Fruchart JC, Najib-Fruchart J, Glineur C, Staels B. 2001. Statin-induced inhibition of the Rho-signaling pathway activates PPARalpha and induces HDL apoA-I. J Clin Invest 107:1423-1432.
32. McKerracher L. 2002. Ganglioside rafts as MAG receptors that mediate blockade of axon growth. Proc Natl Acad Sci USA 99:7811-7813.
33. Merkler D, Metz GA, Raineteau O, Dietz V, Schwab ME, Fouad K. 2001. Locomotor recovery in spinal cord-injured rats treated with an antibody neutralizing the myelin-associated neurite growth inhibitor Nogo-A. J Neurosci 21:3665-3673.
34. Mitchell JA, Akarasereenont P, Thiemermann C, Flower RJ, Vane JR. 1993. Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc Natl Acad Sci USA 90:11693-11697.
35. Monnier PP, Sierra A, Schwab JM, Henke-Fahle S, Mueller BK. 2003. The Rho/ROCK pathway mediates neurite growth-inhibitory activity associated with the chondroitin sulfate proteoglycans of the CNS glial scar. Mol Cell Neurosci 22:319-330.
36. Negishi M, Katoh H. 2002. Rho family GTPases as key regulators for neuronal network formation. J Biochem 132:157-166.
37. Neumann H, Schweigreiter R, Yamashita T, Rosenkranz K, Wekerle H, Barde YA. 2002. Tumor necrosis factor inhibits neurite outgrowth and branching of hippocampal neurons by a rho-dependent mechanism. J Neurosci 22:854-862.
38. Neve RL, Coopersmith R, McPhie DL, Santeufemio C, Pratt KG, Murphy CJ, Lynn SD. 1998. The neuronal growth-associated protein GAP-43 interacts with rabaptin-5 and participates in endocytosis. J Neurosci 18:7757-7767.
39. Pettus BJ, Bielawski J, Porcelli AM, Reames DL, Johnson KR, Morrow J, Chalfant CE, Obeid LM, Hannun YA. 2003. The sphingosine kinase 1/sphingosine-1-phosphate pathway mediates COX-2 induction and PGE2 production in response to TNF-alpha. FASEB J 17:1411-1421.
40. Pyo H, Joe E, Jung S, Lee SH, Jou I. 1999. Gangliosides activate cultured rat brain microglia. J Biol Chem 274:34584-34589.
41. Qiu J, Cai D, Dai H, McAtee M, Hoffman PN, Bregman BS, Filbin MT. 2002. Spinal axon regeneration induced by elevation of cyclic AMP. Neuron 34:895-903.
42. Ramon-Cueto A, Cordero MI, Santos-Benito FF, Avila J. 2000. Functional recovery of paraplegic rats and motor axon regeneration in their spinal cords by olfactory ensheathing glia. Neuron 25:425-435.
43. Rapalino O, Lazarov-Spiegler O, Agranov E, Velan GJ, Yoles E, Fraidakis M, Solomon A, Gepstein R, Katz A, Belkin M, Hadani M, Schwartz M. 1998. Implantation of stimulated homologous macrophages results in partial recovery of paraplegic rats. Nat Med 4:814-821.
44. Resnick DK, Graham SH, Dixon CE, Marion DW. 1998. Role of cyclooxygenase 2 in acute spinal cord injury. J Neurotrauma 15:1005-1013.
45. Ridley AJ. 2001. Rho proteins, PI 3-kinases, and monocyte/macrophage motility. FEBS Lett 498:168-171.
46. Rubin EJ, Gill DM, Boquet P, Popoff MR. 1988. Functional modification of a 21-kilodalton G protein when ADP-ribosylated by exoenzyme C3 of Clostridium botulinum. Mol Cell Biol 8:418-426.
47. Schmeck B, Brunsch M, Seybold J, Krull M, Eichel-Streiber C, Suttorp N, Hippenstiel S. 2003. Rho protein inhibition blocks cyclooxygenase-2 expression by proinflammatory mediators in endothelial cells. Inflammation 27:89-95.
48. Schmitz AA, Govek EE, Bottner B, van Aelst L. 2000. Rho GTPases: signaling, migration, and invasion. Exp Cell Res 261:1-12.
49. Schnell L, Schwab ME. 1990. Axonal regeneration in the rat spinal cord produced by an antibody against myelin-associated neurite growth inhibitors. Nature 343:269-272.
50. Schwab JM, Frei E, Klusman I, Schnell L, Schwab ME, Schluesener HJ. 2001. AIF-1 expression defines a proliferating and alert microglial/macrophage phenotype following spinal cord injury in rats. J Neuroimmunol 119:214-222.
51. Schwab JM, Hirsch S, Brechtel K, Tura A, Adibzadeh M, Stiefel A, Leppert CA, Schluesener HJ, Barth H, Aktories K, Mueller BK. 2002. The Rho-GTPase inhibitor C2IN-C3 induces functional neuronal recovery in a rat model of severe spinal cord injury. Soc Abs Neurosci 204.7.
52. Schwab JM, Schluesener HJ, Laufer S. 2003. COX-3: just another COX or the solitary elusive target of paracetamol? Lancet 361:981-982.
53. Schwab ME, Bartholdi D. 1996. Degeneration and regeneration of axons in the lesioned spinal cord. Physiol Rev 76:319-370.
54. Tapon N, Hall A. 1997. Rho, Rac and Cdc42 GTPases regulate the organization of the actin cytoskeleton. Curr Opin Cell Biol 9:86-92.
55. Tator CH. 1995. Update on the pathophysiology and pathology of acute spinal cord injury. Brain Pathol 5:407-413.
56. Wickelgren I. 2002. Animal studies raise hopes for spinal cord repair. Science 297:178-81.
57. Winton MJ, Dubreuil CI, Lasko D, Leclerk N, McKerracher L. 2002. Characterization of new cell permeable C3-like proteins that inactivate Rho and stimulate neurite outgrowth on inhibitory substrates. J Biol Chem 277:32820-32829.
58. Woolf CJ, Bloechlinger S. 2002. Neuroscience. It takes more than two to Nogo. Science 297:1132-1134.